160 related articles for article (PubMed ID: 37225769)
1. Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants.
Schroeder L; Monno P; Strizek B; Dresbach T; Mueller A; Kipfmueller F
Sci Rep; 2023 May; 13(1):8405. PubMed ID: 37225769
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension.
Schroeder L; Holcher S; Leyens J; Geipel A; Strizek B; Dresbach T; Mueller A; Kipfmueller F
Eur J Pediatr; 2023 Jul; 182(7):3165-3174. PubMed ID: 37100959
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil in Term and Premature Infants: A Systematic Review.
Perez KM; Laughon M
Clin Ther; 2015 Nov; 37(11):2598-2607.e1. PubMed ID: 26490498
[TBL] [Abstract][Full Text] [Related]
4. Continuous intravenous sildenafil as an early treatment in neonates with congenital diaphragmatic hernia.
Kipfmueller F; Schroeder L; Berg C; Heindel K; Bartmann P; Mueller A
Pediatr Pulmonol; 2018 Apr; 53(4):452-460. PubMed ID: 29316358
[TBL] [Abstract][Full Text] [Related]
5. Continuous and intermittent administration of intravenous sildenafil in critically ill infants with pulmonary hypertension.
Sharma C; Burns J; Kulkarni A; Cerise JE; Molina Berganza F; Hayes DA
Pediatr Pulmonol; 2021 Sep; 56(9):2973-2978. PubMed ID: 34143564
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil Treatment of Infants With Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
Backes CH; Reagan PB; Smith CV; Jadcherla SR; Slaughter JL
Hosp Pediatr; 2016 Jan; 6(1):27-33. PubMed ID: 26666265
[TBL] [Abstract][Full Text] [Related]
7. Intravenous sildenafil in the management of pulmonary hypertension associated with congenital diaphragmatic hernia.
Bialkowski A; Moenkemeyer F; Patel N
Eur J Pediatr Surg; 2015 Apr; 25(2):171-6. PubMed ID: 24163194
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil therapy in bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective study of efficacy and safety.
Tan K; Krishnamurthy MB; O'Heney JL; Paul E; Sehgal A
Eur J Pediatr; 2015 Aug; 174(8):1109-15. PubMed ID: 25796626
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension.
Rhee SJ; Shin SH; Oh J; Jung YH; Choi CW; Kim HS; Yu KS
Sci Rep; 2022 May; 12(1):7393. PubMed ID: 35513541
[TBL] [Abstract][Full Text] [Related]
10. Use of sildenafil in an infant with persistent pulmonary hypertension secondary to lung and renal hypoplasia - a case report.
Lavie-Nevo K; Harris KC; Ting JY
BMC Pediatr; 2019 Nov; 19(1):416. PubMed ID: 31690278
[TBL] [Abstract][Full Text] [Related]
11. Intermittent intravenous sildenafil for pulmonary hypertension management in neonates and infants.
Stultz JS; Puthoff T; Backes C; Nahata MC
Am J Health Syst Pharm; 2013 Mar; 70(5):407-13. PubMed ID: 23413163
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits?
Nyp M; Sandritter T; Poppinga N; Simon C; Truog WE
J Perinatol; 2012 Jan; 32(1):64-9. PubMed ID: 21941230
[TBL] [Abstract][Full Text] [Related]
13. Intravenous sildenafil i.v. as rescue treatment for refractory pulmonary hypertension in extremely preterm infants.
Steiner M; Salzer U; Baumgartner S; Waldhoer T; Klebermass-Schrehof K; Wald M; Langgartner M; Berger A
Klin Padiatr; 2014 Jul; 226(4):211-5. PubMed ID: 25010126
[TBL] [Abstract][Full Text] [Related]
14. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the safety of intermittent intravenous sildenafil in infants with pulmonary hypertension.
Darland LK; Dinh KL; Kim S; Placencia JL; Varghese NP; Ruiz F; Mallory GB; Fernandes CJ
Pediatr Pulmonol; 2017 Feb; 52(2):232-237. PubMed ID: 27340796
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
Hilgendorff A; Apitz C; Bonnet D; Hansmann G
Heart; 2016 May; 102 Suppl 2():ii49-56. PubMed ID: 27053698
[TBL] [Abstract][Full Text] [Related]
17. An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants.
Thakkar N; Gonzalez D; Cohen-Wolkowiez M; Massaro MM; Bernhardt J; Zane NR; Laughon MM
J Perinatol; 2016 Sep; 36(9):744-7. PubMed ID: 27171763
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil for the Treatment of Pulmonary Arterial Hypertension in Infants with Bronchopulmonary Dysplasia.
Trottier-Boucher MN; Lapointe A; Malo J; Fournier A; Raboisson MJ; Martin B; Moussa A
Pediatr Cardiol; 2015 Aug; 36(6):1255-60. PubMed ID: 25824807
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension specific treatment in infants with bronchopulmonary dysplasia.
Kadmon G; Schiller O; Dagan T; Bruckheimer E; Birk E; Schonfeld T
Pediatr Pulmonol; 2017 Jan; 52(1):77-83. PubMed ID: 27333438
[TBL] [Abstract][Full Text] [Related]
20. Neonatal pulmonary hypertension after severe early-onset fetal growth restriction: post hoc reflections on the Dutch STRIDER study.
Pels A; Onland W; Berger RMF; van Heijst AFJ; Lopriore E; Reiss IKM; Limpens J; Gordijn SJ; Ganzevoort W
Eur J Pediatr; 2022 Apr; 181(4):1709-1718. PubMed ID: 35018508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]